PT-141 represents a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors within the body, causing to augmented sexual function. Clinical studies have indicated that PT-141 has the potential to effectively treat a variety of sexual dys